Literature DB >> 32293512

Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.

Pankaj Chaudhary1, Lee D Gibbs2, Sayantan Maji2, Cheryl M Lewis3, Sumihiro Suzuki4, Jamboor K Vishwanatha5,6.   

Abstract

After publication of the original article [1], we were notified that the wrong version of Fig. 2b has been published.

Entities:  

Year:  2020        PMID： 32293512      PMCID： PMC7087376          DOI： 10.1186/s13058-020-01268-9

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN： 1465-5411            Impact factor:   6.466


Correction to: Breast Cancer Research (2020) 22:11 https://doi.org/10.1186/s13058-020-1251-8 After publication of the original article [1], we were notified that the wrong version of Fig. 2b has been published. Below the correct version of Fig. 2b”.
  1 in total

1.  Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.

Authors:  Pankaj Chaudhary; Lee D Gibbs; Sayantan Maji; Cheryl M Lewis; Sumihiro Suzuki; Jamboor K Vishwanatha
Journal:  Breast Cancer Res       Date:  2020-01-28       Impact factor: 6.466
  1 in total
  3 in total

Review 1.  Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer.

Authors:  Manish Charan; Ajeet K Verma; Shahid Hussain; Swati Misri; Sanjay Mishra; Sarmila Majumder; Bhuvaneswari Ramaswamy; Dinesh Ahirwar; Ramesh K Ganju
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

Review 2.  Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis.

Authors:  Yufang Tan; Xiao Luo; Wenchang Lv; Weijie Hu; Chongru Zhao; Mingchen Xiong; Yi Yi; Dawei Wang; Yichen Wang; Haiping Wang; Yiping Wu; Qi Zhang
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

3.  Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial-mesenchymal plasticity of human peritoneal mesothelial cells.

Authors:  Lingling Gao; Xin Nie; Rui Gou; Yuexin Hu; Hui Dong; Xiao Li; Bei Lin
Journal:  J Cell Mol Med       Date:  2021-11-01       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.